Pediatric myocardial slices keep beating in the lab for months
Human pediatric heart tissue can now be studied far beyond the operating room, with small surgical specimens maintaining measurable calcium signaling for prolonged periods under passive culture. In this preprint, investigators adapted a free-floating rocking culture system for atrial and ventricular slices taken from children and adults undergoing surgery for congenital heart disease, then followed those slices through repeated functional testing over time.
The work matters because pediatric cardiac biology is not simply a smaller version of adult physiology. Developing myocardium, repaired congenital anatomy, and age-dependent remodeling all influence contractile behavior, adrenergic responsiveness, and tissue resilience. A model that preserves native tissue architecture while allowing repeated measurements offers a rare bridge between bedside surgery and preclinical pharmacology.
Repeated calcium measurements came from all four chambers
Myocardial specimens came from 41 cardiac surgery patients, spanning 1 day to 49 years of age, with a mean age of 7.7 ± 11.1 years. Atrial and ventricular tissue was sliced and studied either acutely or maintained in culture without electrical or mechanical stimulation. Calcium transients were then recorded during external pacing at 0.2 to 2 Hz, and the slices showed the expected frequency-dependent shortening of calcium transient behavior.
Every chamber yielded measurable signals. Mean interslice coefficient of variation was 11.1%, and intraslice variation was 7.6%, suggesting the platform remained reasonably reproducible despite the biological complexity of surgical human tissue. Viability after slicing averaged 85.8 ± 5.6% and remained 78.8 ± 5.0% after 3 to 5 hours, supporting the idea that the sectioning process itself did not immediately erase useful physiology.
The signal did not vanish quickly in culture. Calcium transients remained detectable through 178 days in atrial slices and 119 days in ventricular slices. One sentence captures the central result better than any framing device: these slices stayed alive and functional for months.
Adrenergic responsiveness persisted deep into culture
The most clinically relevant finding is not just that the tissue survived, but that it still answered pharmacologic challenge. Beta-adrenergic agonists shortened calcium transient duration, with isoproterenol producing a 32% reduction in atrial slices and a 25% reduction in ventricular slices at 0.3 Hz. Norepinephrine was also used in the experimental workflow, reinforcing that the preparation could interrogate sympathetic signaling in a human pediatric substrate.
This response is biologically plausible. Beta-adrenergic stimulation raises intracellular cyclic AMP, accelerates calcium handling, and shortens the systolic-calcium signal that underlies contraction. In a model that keeps the myocardium organized in native layers, that pathway can be probed without the distortions introduced by cell dissociation or engineered constructs. The result is a more faithful readout of how pediatric heart tissue may react to inotropes, stress hormones, or experimental compounds.
Selected atrial slices retained responsiveness to isoproterenol to approximately 120 days, while selected ventricular slices remained responsive to about 60 days. Those durations are long enough to support longitudinal pharmacology, repeated baseline testing, and within-specimen comparisons over time. For investigators developing therapies for congenital heart disease, the practical consequence is straightforward: one surgical sample can now yield multiple experimental windows instead of a single short-lived assay.
Tissue architecture stayed partly intact as some molecular programs changed
Histologic evaluation preserved selected structural features, even as the culture period introduced molecular drift. Some extracellular matrix and apoptosis-related transcripts changed over time, indicating that passive culture is not a perfect stand-in for the in vivo myocardium. The tissue remains useful, but not frozen in time; it continues to remodel, adapt, and respond to the absence of blood flow, neurohumoral input, and mechanical loading.
That tradeoff is common in ex vivo biology. Preserving native architecture gives the model power, while prolonged culture without electrical or mechanical stimulation can also shift transcriptional programs that normally depend on stretch, perfusion, and cell-cell signaling. The key question is whether the system remains close enough to native function to answer targeted mechanistic questions. Here, repeated calcium transients and retained drug responsiveness argue that it does.
Why this platform could change pediatric cardiac preclinical testing
Current pediatric cardiac research often depends on animal models, isolated cells, or engineered tissues that do not fully capture the complexity of congenital disease. Human myocardial slices offer a different path. They retain chamber-specific tissue context, permit repeated pacing-based readouts, and allow direct testing of compounds on surgical material that already carries the molecular history of the patient.
For congenital heart disease, that matters in several ways. Drugs that alter calcium cycling can be evaluated in atrial and ventricular tissue from the same patient population in which those drugs might eventually be used. Disease-specific remodeling, prior interventions, age-related differences, and chamber-specific vulnerability can all influence response. A slice platform cannot replace clinical trials, but it can narrow the gap between molecular pharmacology and bedside decision-making.
The model may also help researchers study developmental electrophysiology, postoperative myocardial dysfunction, and the biology of tissue from infants and children whose hearts are difficult to model otherwise. Because the tissue remained testable for months, investigators can imagine paired experiments using the same specimen across time, comparing baseline physiology with later responses to adrenergic stimulation or other interventions.
Preprint status leaves important questions open
This study remains a preprint and has not undergone peer review, so the data should be viewed as promising rather than definitive. The abstract does not provide detailed donor-level breakdowns by lesion type, medication exposure, surgical procedure, or age subgroup, and those factors could shape tissue resilience and signaling behavior. The transcriptional changes in extracellular matrix and apoptosis pathways also raise a practical concern: prolonged culture preserves function, but it may not preserve every molecular feature equally well.
Even with those limits, the experimental message is concrete. Small pediatric myocardial specimens can be sliced, cultured passively, and interrogated repeatedly for calcium handling and beta-adrenergic drug response over long periods. The platform gives congenital heart research a human tissue system with far more staying power than conventional acute preparations, and it does so without losing the core physiologic readout that makes the model valuable in the first place.